News
Figs (FIGS) Beats Q3 Earnings and Revenue Estimates
Figs (FIGS) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.01 per share a year ago. These figures are
Huntsman (HUN) Reports Q3 Loss, Tops Revenue Estimates
Huntsman (HUN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to earnings of $0.1 per share a year ago. These figures are
Zymeworks Inc. (ZYME) Reports Q3 Loss, Lags Revenue Estimates
Zymeworks Inc. (ZYME) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.39 per share a year ago. These figures
Universal Logistics (ULH) Beats Q3 Earnings Estimates
Universal Logistics (ULH) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $1.01 per share a year ago. These
Five9 (FIVN) Tops Q3 Earnings and Revenue Estimates
Five9 (FIVN) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.67 per share a year ago. These figures are
Microchip Technology (MCHP) Q2 Earnings and Revenues Top Estimates
Microchip Technology (MCHP) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.46 per share a year ago
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates
Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.13. This compares to earnings of $0.02 per share a year ago. These
BioLife Solutions, Inc. (BLFS) Surpasses Q3 Earnings and Revenue Estimates
BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.02 per share a
VTEX (VTEX) Meets Q3 Earnings Estimates
VTEX (VTEX) came out with quarterly earnings of $0.03 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago. These figures are adjusted for
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.31 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.36 per share a year ago. These figures
EOG Resources (EOG) Surpasses Q3 Earnings Estimates
EOG Resources (EOG) came out with quarterly earnings of $2.71 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $2.89 per share a year ago. These
Camden (CPT) Tops Q3 FFO Estimates
Camden (CPT) came out with quarterly funds from operations (FFO) of $1.7 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to FFO of $1.71 per share a year ago. These
Dropbox (DBX) Q3 Earnings and Revenues Beat Estimates
Dropbox (DBX) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.6 per share a year ago. These figures are
Solventum (SOLV) Surpasses Q3 Earnings and Revenue Estimates
Solventum (SOLV) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.64 per share a year ago. These figures
Block (XYZ) Misses Q3 Earnings and Revenue Estimates
Block (XYZ) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.88 per share a year ago. These figures are
Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates
Doximity (DOCS) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.3 per share a year ago. These figures
Celanese (CE) Beats Q3 Earnings Estimates
Celanese (CE) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $2.44 per share a year ago. These figures are
Monster Beverage (MNST) Surpasses Q3 Earnings and Revenue Estimates
Monster Beverage (MNST) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.4 per share a year ago. These
Akamai Technologies (AKAM) Beats Q3 Earnings and Revenue Estimates
Akamai Technologies (AKAM) came out with quarterly earnings of $1.86 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.59 per share a year ago
Progyny (PGNY) Q3 Earnings and Revenues Beat Estimates
Progyny (PGNY) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.4 per share a year ago. These figures are
Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates
Lineage Cell (LCTX) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.02 per share a year ago. These figures are
Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Misses Revenue Estimates
Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $0.92 per share versus the Zacks Consensus Estimate of a loss of $1.02. This compares to a loss of $1.34 per share a year ago
Airbnb, Inc. (ABNB) Misses Q3 Earnings Estimates
Airbnb, Inc. (ABNB) came out with quarterly earnings of $2.21 per share, missing the Zacks Consensus Estimate of $2.29 per share. This compares to earnings of $2.13 per share a year ago. These
Gen Digital (GEN) Q2 Earnings and Revenues Top Estimates
Gen Digital (GEN) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.54 per share a year ago. These figures
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q3 Loss, Lags Revenue Estimates
Crinetics Pharmaceuticals, Inc. (CRNX) came out with a quarterly loss of $1.38 per share versus the Zacks Consensus Estimate of a loss of $1.27. This compares to a loss of $0.96 per share a year


